Liuzzo, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 6.984
EU - Europa 5.782
AS - Asia 5.146
SA - Sud America 993
AF - Africa 137
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 12
Totale 19.069
Nazione #
US - Stati Uniti d'America 6.782
SG - Singapore 2.341
DE - Germania 2.140
CN - Cina 1.303
IT - Italia 836
SE - Svezia 812
BR - Brasile 785
FR - Francia 499
VN - Vietnam 458
UA - Ucraina 342
GB - Regno Unito 258
IE - Irlanda 215
FI - Finlandia 183
IN - India 177
ID - Indonesia 155
JP - Giappone 137
RU - Federazione Russa 112
HK - Hong Kong 109
AR - Argentina 97
CA - Canada 94
PL - Polonia 83
TR - Turchia 79
MX - Messico 68
BD - Bangladesh 67
NL - Olanda 55
AT - Austria 51
IQ - Iraq 49
ES - Italia 44
ZA - Sudafrica 44
BE - Belgio 34
KR - Corea 32
EC - Ecuador 27
CL - Cile 25
IR - Iran 24
JO - Giordania 22
PK - Pakistan 22
CI - Costa d'Avorio 20
LT - Lituania 20
CZ - Repubblica Ceca 19
CO - Colombia 18
TW - Taiwan 17
CH - Svizzera 16
SA - Arabia Saudita 15
VE - Venezuela 15
UZ - Uzbekistan 14
AU - Australia 13
TN - Tunisia 13
KE - Kenya 12
AZ - Azerbaigian 11
DZ - Algeria 11
IL - Israele 11
NP - Nepal 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
MA - Marocco 10
EG - Egitto 9
PE - Perù 9
PH - Filippine 9
LB - Libano 8
PT - Portogallo 8
OM - Oman 7
BO - Bolivia 6
JM - Giamaica 6
MY - Malesia 6
EU - Europa 5
GE - Georgia 5
GR - Grecia 5
HN - Honduras 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LK - Sri Lanka 5
PA - Panama 5
PY - Paraguay 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
CR - Costa Rica 4
CY - Cipro 4
DO - Repubblica Dominicana 4
KH - Cambogia 4
LV - Lettonia 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
HR - Croazia 3
MK - Macedonia 3
SN - Senegal 3
A1 - Anonimo 2
AM - Armenia 2
BB - Barbados 2
GA - Gabon 2
GY - Guiana 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MM - Myanmar 2
Totale 19.025
Città #
Singapore 1.382
Chandler 882
Ashburn 755
San Jose 657
New York 331
Rome 228
Jacksonville 221
Dublin 211
Beijing 199
San Mateo 190
Los Angeles 188
Nanjing 184
Milan 175
Ho Chi Minh City 173
Jakarta 134
Lauterbourg 131
St Louis 129
Munich 125
Tokyo 122
Hefei 121
Wilmington 107
Nürnberg 106
Marseille 102
Boston 101
Hanoi 101
Hong Kong 93
Ann Arbor 87
Frankfurt am Main 87
Cattolica 86
Houston 86
Dearborn 84
The Dalles 83
Woodbridge 72
Moscow 71
Nanchang 70
São Paulo 68
Bremen 67
Helsinki 65
Buffalo 56
Chicago 56
Dallas 54
Seattle 54
Lawrence 53
Santa Clara 49
London 48
Redwood City 48
Warsaw 48
North Bergen 46
Izmir 42
Princeton 42
Montreal 38
Council Bluffs 37
Düsseldorf 37
Fairfield 36
Orem 36
Tianjin 36
Turku 36
Atlanta 35
Brussels 34
Kent 33
Leawood 33
Da Nang 32
Nuremberg 31
Vienna 31
Denver 30
Mexico City 30
Paris 30
Stockholm 30
Rio de Janeiro 29
Boardman 28
Brooklyn 28
Fremont 28
Hangzhou 28
Kunming 28
Seoul 28
Zhengzhou 28
Chennai 26
Poplar 26
Guangzhou 25
Pune 25
Shanghai 24
Mountain View 23
Amman 22
Amsterdam 22
Johannesburg 22
Shenyang 22
Detroit 21
Toronto 21
Abidjan 20
Belo Horizonte 20
Changsha 20
Hebei 20
University Park 20
Manchester 19
San Francisco 19
Baghdad 18
Haiphong 18
Mumbai 18
Hyderabad 17
Lappeenranta 17
Totale 10.005
Nome #
Paradoxical preservation of vascular function in severe obesity 355
Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus 313
Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes 272
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome 240
GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation 234
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Predictors of Postoperative Atrial Fibrillation in Patients with Coronary Artery Disease Undergoing Cardiopulmonary Bypass: A Possible Role for Myocardial Ischemia and Atrial Inflammation 221
Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability 217
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 215
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 209
Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects 202
Endothelial progenitor cells in morbid obesity 201
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 198
Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients 197
Predictors of postoperative atrial fibrillation in patients with coronary artery disease undergoing cardiopulmonary bypass: a possible role for myocardial ischemia and atrial inflammation 196
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 194
Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure. 189
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 189
Thromboxane production in morbidly obese subjects 189
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 188
Air Pollution and Coronary Plaque Vulnerability and Instability: An Optical Coherence Tomography Study 188
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 183
Pioglitazone reduces monocyte activation in type 2 diabetes 183
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment 181
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 178
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 177
CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes 175
Reduced CD31 expression on CD14(+)CD16(+) monocyte subset in acute coronary syndromes 173
High telomerase activity in neutrophils from unstable coronary plaques 171
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 169
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 169
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 169
Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives 169
Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells 168
Increased PTPN22 Expression and Defective CREB Activation Impair Regulatory T-Cell Differentiation in Non-ST-Segment Elevation Acute Coronary Syndromes 166
Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes 166
Indoleamine 2,3-dioxygenase (IDO) enzyme links innate immunity and altered T-cell differentiation in Non-ST segment elevation acute coronary syndrome 164
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 163
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 163
Identification of unique adaptive immune system signature in acute coronary syndromes 163
Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion 161
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 160
Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients 159
Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries 159
Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus 158
Correlation between CD4 + CD28 null T lymphocytes, regulatory T cells and plaque rupture: An Optical Coherence Tomography study in Acute Coronary Syndromes 157
Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions 156
Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque Rupture 155
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 154
A Novel Monocyte Subset as a Unique Signature of Atherosclerotic Plaque Rupture 154
Use of Levosimendan as bridge therapy to surgical correction of post-infarction ventricular septal defect: a case report 152
Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: Pathogenetic implications 151
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 149
Brain-derived neurotrophic factor in patients with acute coronary syndrome 147
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 146
Infarct-related artery occlusion, tissue markers of ischemia, and increased apoptosis in the peri-infarct viable myocardium. 146
Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome 145
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 144
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 143
Effect of Remote Ischemic Preconditioning on Platelet Activation Induced by Coronary Procedures 141
High-dose atorvastatin reduces oxidative stress of ischemia/reperfusion injury after isogeneic kidney transplantation in rats: in vivo, preclinical, case–control, open-label study 139
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 138
Predicting the no-reflow phenomenon following successful percutaneous coronary intervention 137
Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The “INOCA versus Obstructive CCS” Challenge 136
Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome 135
Restricted T-Cell Repertoire in the Epicardial Adipose Tissue of Non-ST Segment Elevation Myocardial Infarction Patients 133
Contemporary Analysis of cardiac Tamponade Etiologies, Treatments, and Outcomes: the CATEO Study 133
Advances in mechanisms, imaging and management of the unstable plaque 133
Microbial signature of plaque and gut in acute coronary syndrome 130
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial 130
From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19 130
Air pollution and plaque healing in acute coronary syndromes 129
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial 129
Brain-derived neurotrophic factor in patients with acute coronary syndrome 129
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 128
Coronary CT Angiography in the Emergency Department: State of the Art and Future Perspectives 128
Platelet hyaluronidase 2 enrichment in acute coronary syndromes: a conceivable role in monocyte-platelet aggregate formation 127
The cardiovascular relevance of celiac disease 126
Where Does Inflammation Fit? 125
Perilipin 2 levels are increased in patients with in-stent neoatherosclerosis: A clue to mechanisms of accelerated plaque formation after drug-eluting stent implantation 123
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 122
Allergic Inflammation Is Associated With Coronary Instability and a Worse Clinical Outcome After Acute Myocardial Infarction 122
Identification of unique adaptive immune system signature in acute coronary syndromes 121
Response to Letter Regarding Article, "Allergic Inflammation Is Associated With Coronary Instability and a Worse Clinical Outcome After Acute Myocardial Infarction" 120
Not all plaque ruptures are born equal: An optical coherence tomography study 118
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 117
Inflammation in coronary atherosclerosis: diagnosis and treatment 117
Incidence and predictors of thrombotic complications in 4742 patients with COVID-19 or other acute infectious respiratory diseases: A propensity score-matched study 117
Inflammation across the spectrum of hypertrophic cardiac phenotypes 116
Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives 116
Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score 115
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 115
Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis 113
Upregulated monocyte expression of PLIN2 is associated with early arterial injury in children with overweight/obesity 112
Clinical Characteristics, Management, and Outcomes in Cardiogenic Shock: Insights From a High-Volume Italian Cardiac Intensive Care Unit 109
Personalized clinical phenotyping through systems medicine and artificial intelligence 109
Colchicine in ischemic heart disease: the good, the bad and the ugly 109
Inflammation in coronary atherosclerosis: diagnosis and treatment 107
Sex-Related Differences in the Prognostic Role of Acetylcholine Provocation Testing 107
Totale 15.889
Categoria #
all - tutte 71.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 0 0 0 0 0 0 131 25
2021/20221.165 49 73 21 46 55 60 27 197 46 118 239 234
2022/20232.503 328 340 221 399 127 285 157 193 276 72 54 51
2023/20241.434 44 312 57 72 59 330 77 66 35 63 151 168
2024/20252.943 67 99 237 108 238 83 102 121 445 315 645 483
2025/20267.135 981 294 405 978 1.270 396 1.245 377 538 581 70 0
Totale 19.305